• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
LeadershipPolitics

Trump Spurns Big Pharma Campaign Donations Amid Opioid Epidemic

By
Justin Sink
Justin Sink
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Justin Sink
Justin Sink
and
Bloomberg
Bloomberg
Down Arrow Button Icon
April 24, 2019, 4:30 PM ET
US-POLITICS-TRUMP-drugs-SUMMIT
US President Donald Trump speaks at the Rx Drug Abuse and Heroin Summit on April 24, 2019, in Atlanta, Georgia. JIM WATSON AFP/Getty Images

President Donald Trump spurned campaign contributions from the pharmaceutical industry on Wednesday, calling the industry out for its role in a national opioid addiction epidemic.

“I don’t want their money,” Trump said at an event on drug addiction in Atlanta. “They have got to do what is right.”

Trump’s administration has stepped up scrutiny of pharmaceutical companies as part of an initiative to combat addiction to prescription painkillers. Federal prosecutors on Tuesday charged opioid distributor Rochester Drug Cooperative and its former chief executive with felonies — the first case of its kind related to the opioid crisis.

“We are holding big pharma accountable,” Trump said.

About the Authors
By Justin Sink
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.